Sökresultat - "Wendtner, Clemens‐Martin"

Burden of COVID-19 in immunocompromised patients in Germany: a retrospective, observational Study on Health Insurance Data from 2021 to 2022

Weinmann-Menke, Julia, Wendtner, Clemens-Martin, Häckl, Dennis^{Aff3, Aff4}, Lohe, Vanessa, Dang, Phi Long, Jah, Fungwe, Kneidinger, Nikolaus^{Aff6, Aff7, IDs1501002502516w_cor1}

Clinical trials in early-stage CLL: what has been learned and what's next?

Hoechstetter, Manuela A.¹ (AUTHOR) Manuela.Hoechstetter@med.uni-muenchen.de, Wendtner, Clemens-Martin¹ (AUTHOR)

Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial

Al-Sawaf, Othman^{Aff1, Aff2, Aff3, IDs41591023027229_cor1}, Ligtvoet, Rudy, Robrecht, Sandra, Stumpf, Janina, Fink, Anna-Maria, Tausch, Eugen, Schneider, Christof, Boettcher, Sebastian, Mikusko, Martin, Ritgen, Matthias, Schetelig, Johannes, von Tresckow, Julia, Vehling-Kaiser, Ursula, Gaska, Tobias, Wendtner, Clemens Martin, Chapuy, Bjoern^{Aff13, Aff14}, Fischer, Kirsten, Kreuzer, Karl-Anton, Stilgenbauer, Stephan, Staber, Philipp, Niemann, Carsten, Hallek, Michael, Eichhorst, Barbara^{Aff1, IDs41591023027229_cor23}

Negative feedback regulation of MAPK signaling is an important driver of chronic lymphocytic leukemia progression

Ecker, Veronika, Brandmeier, Lisa, Stumpf, Martina, Giansanti, Piero, Moreira, Aida Varela, Pfeuffer, Lisa, Fens, Marcel H.A.M., Lu, Junyan, Kuster, Bernhard, Engleitner, Thomas, Heidegger, Simon, Rad, Roland, Ringshausen, Ingo, Zenz, Thorsten, Wendtner, Clemens-Martin, Müschen, Markus, Jellusova, Julia, Ruland, Jürgen, Buchner, Maike

High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations

Fürstenau, Moritz, Thus, Yvonne J., Robrecht, Sandra, Mellink, Clemens H. M., van der Kevie-Kersemaekers, Anne-Marie, Dubois, Julie, von Tresckow, Julia, Patz, Michaela, Gregor, Michael, Thornton, Patrick, Staber, Philipp B., Tadmor, Tamar, Levin, Mark-David, da Cunha-Bang, Caspar, Schneider, Christof, Poulsen, Christian Bjoern, Illmer, Thomas, Schöttker, Björn, Janssens, Ann, Christiansen, Ilse, Nösslinger, Thomas, Baumann, Michael, Hebart, Holger, Gaska, Tobias, Regelink, Josien C., Dompeling, Ellen C., Lindström, Vesa, Juliusson, Gunnar, Widmer, Anouk, Goede, Jeroen, Goldschmidt, Neta, Simon, Florian, De Silva, Nisha, Fink, Anna-Maria, Fischer, Kirsten, Wendtner, Clemens-Martin, Ritgen, Matthias, Brüggemann, Monika, Tausch, Eugen, Spaargaren, Marcel, Eldering, Eric, Stilgenbauer, Stephan, Niemann, Carsten U., Hallek, Michael, Eichhorst, Barbara, Kreuzer, Karl-Anton, Kater, Arnon P.

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Analysis of immune responses in patients with CLL after heterologous COVID-19 vaccination

Lee, Hye Kyung ^∗, Hoechstetter, Manuela A. ^∗, Buchner, Maike ^∗, Pham, Trang Thu, Huh, Jin Won, Müller, Katharina, Zange, Sabine, von Buttlar, Heiner, Girl, Philipp, Wölfel, Roman, Brandmeier, Lisa, Pfeuffer, Lisa, Furth, Priscilla A., Wendtner, Clemens-Martin, Hennighausen, Lothar

Clinical and virological features of first human monkeypox cases in Germany

Noe, Sebastian, Zange, Sabine^{Aff2, Aff5}, Seilmaier, Michael, Antwerpen, Markus H.^{Aff2, Aff5}, Fenzl, Thomas, Schneider, Jochen^{Aff3, Aff5}, Spinner, Christoph D.^{Aff3, Aff5}, Bugert, Joachim J.^{Aff2, Aff5}, Wendtner, Clemens-Martin, Wölfel, Roman^{Aff2, Aff5, IDs1501002201874z_cor10}

sCD25 as an independent adverse prognostic factor in adult patients with HLH: results of a multicenter retrospective study

Wimmer, Thomas, Mattes, Raphael, Stemmler, Hans-Joachim, Hauck, Fabian, Schulze-Koops, Hendrik, Stecher, Stephanie-Susanne, Starck, Michael, Wendtner, Clemens-Martin, Bojko, Peter, Hentrich, Marcus, Nickel, Katharina E., Götze, Katharina S., Bassermann, Florian, von Bergwelt-Baildon, Michael, Spiekermann, Karsten

Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination

Tscherne, Alina, Schwarz, Jan Hendrik, Rohde, Cornelius, Kupke, Alexandra, Kalodimou, Georgia, Limpinsel, Leonard, Okba, Nisreen M. A., Bošnjak, Berislav, Sandrock, Inga, Odak, Ivan, Halwe, Sandro, Sauerhering, Lucie, Brosinski, Katrin, Liangliang, Nan, Duell, Elke, Jany, Sylvia, Freudenstein, Astrid, Schmidt, Jörg, Werner, Anke, Serra, Michelle Gellhorn, Klüver, Michael, Guggemos, Wolfgang, Seilmaier, Michael, Wendtner, Clemens-Martin, Förster, Reinhold, Haagmans, Bart L., Becker, Stephan, Sutter, Gerd, Volz, Asisa

Sequential treatment with bendamustine, obinutuzumab (GA101) and Ibrutinib in chronic lymphocytic leukemia (CLL): final results of the CLL2-BIG trial

von Tresckow, Julia^{Aff1, Aff2, IDs41375022016297_cor1}, Cramer, Paula, Robrecht, Sandra, Langerbeins, Petra, Fink, Anna-Maria, Al-Sawaf, Othman, Fürstenau, Moritz, Illmer, Thomas, Klaproth, Holger, Tausch, Eugen, Ritgen, Matthias, Fischer, Kirsten, Wendtner, Clemens-Martin^{Aff1, Aff7}, Kreuzer, Karl-Anton, Stilgenbauer, Stephan^{Aff5, Aff8}, Böttcher, Sebastian, Eichhorst, Barbara F., Hallek, Michael

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

The CLL12 trial: ibrutinib vs placebo in treatment-naïve, early-stage chronic lymphocytic leukemia

Langerbeins, Petra ^*, Zhang, Can, Robrecht, Sandra, Cramer, Paula, Fürstenau, Moritz, Al-Sawaf, Othman, von Tresckow, Julia, Fink, Anna-Maria, Kreuzer, Karl-Anton, Vehling-Kaiser, Ursula, Tausch, Eugen, Müller, Lothar, Eckart, Michael Josef, Schlag, Rudolf, Freier, Werner, Gaska, Tobias, Balser, Christina, Reiser, Marcel, Stauch, Martina, Wendtner, Clemens-Martin, Fischer, Kirsten, Stilgenbauer, Stephan, Eichhorst, Barbara, Hallek, Michael

Durable remissions following combined targeted therapy in patients with CLL harboring TP53 deletions and/or mutations

Cramer, Paula ^*, Tausch, Eugen, von Tresckow, Julia, Giza, Adam, Robrecht, Sandra, Schneider, Christof, Fürstenau, Moritz, Langerbeins, Petra, Al-Sawaf, Othman, Pelzer, Benedikt W., Fink, Anna Maria, Fischer, Kirsten, Wendtner, Clemens-Martin, Eichhorst, Barbara, Kneba, Michael, Stilgenbauer, Stephan, Hallek, Michael

Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial

Al-Sawaf, Othman, Zhang, Can, Tandon, Maneesh, Sinha, Arijit, Fink, Anna-Maria, Robrecht, Sandra, Samoylova, Olga, Liberati, Anna M, Pinilla-Ibarz, Javier, Opat, Stephen, Sivcheva, Liliya, Le Dû, Katell, Fogliatto, Laura M, Niemann, Carsten U, Weinkove, Robert, Robinson, Sue, Kipps, Thomas J, Tausch, Eugen, Schary, William, Ritgen, Matthias, Wendtner, Clemens-Martin, Kreuzer, Karl-Anton, Eichhorst, Barbara, Stilgenbauer, Stephan, Hallek, Michael ^*, Fischer, Kirsten

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.